Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Puylaert currently holds 82,335 shares of SOPHiA GENETICS SA (SOPH), valued at approximately $0. This represents their equity stake as Chief Sales Officer.
Based on SEC Form 4 filings, Kevin Puylaert has been a net seller of SOPH stock. They have purchased $0 and sold $14 worth of shares.
Kevin Puylaert's most recent insider trade was on Apr 2, 2026, when they sold 82,335 shares at $0.00 per share.
Kevin Puylaert serves as Chief Sales Officer at SOPHiA GENETICS SA (SOPH). They have executed 3 insider transactions totaling $14 over their tenure at the company.
Kevin Puylaert holds the position of Chief Sales Officer at SOPHiA GENETICS SA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Kevin Puylaert has shown a selling trading pattern, with $0 in total purchases and $14 in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Puylaert was on Mar 31, 2026, when they sold $14 worth of SOPH shares. This transaction involved 3 shares at $4.71 per share.
Kevin Puylaert currently owns 82,335 shares of SOPHiA GENETICS SA (SOPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Puylaert's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Puylaert has 3 Form 4 filings on record as an insider at SOPHiA GENETICS SA.
Set alerts for Kevin Puylaert and 40,000+ other insiders.